Search Results - Chen, Hung‐Jen
- Showing 1 - 20 results of 25
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma by Chen, Hung-Jen, Tu, Chih-Yen, Huang, Kuo-Yang, Chien, Chun-Ru, Hsia, Te-Chun
Published 2020Text -
10
-
11
Comparison of recurrence risk between patients with clinically node‐positive and ‐negative stage I non‐small cell lung cancer following surgery: A propensity score matching analysi... by Huang, Kuo‐Yang, Chen, Hung‐Jen, Lin, Ching‐Hsiung, Wang, Bing‐Yen, Cheng, Ching‐Yuan, Lin, Sheng‐Hao
Published 2022Text -
12
-
13
Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in EGFR Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center, Prospective, Double-Blin... by Li, Chia-Ling, Hsia, Te-Chun, Yang, Su-Tso, Chao, Kun-San Clifford, Tu, Chih-Yen, Chen, Hung-Jen, Li, Chia-Hsiang
Published 2022Text -
14
The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department by Chen, Wei-Cheng, Huang, Kuo-Yang, Yao, Chih-Wei, Wu, Cing-Feng, Liang, Shinn-Jye, Li, Chia-Hsiang, Tu, Chih-Yeh, Chen, Hung-Jen
Published 2016Text -
15
The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan by Cheng, Wen‐Chien, Shen, Yi‐Cheng, Chien, Chun‐Ru, Liao, Wei‐Chih, Chen, Chia‐Hung, Hsia, Te‐Chun, Tu, Chih‐Yeh, Chen, Hung‐Jen
Published 2022Text -
16
When to add anti-angiogenesis drugs to EGFR-mutated metastatic non–small cell lung cancer patients: a real-world study from Taiwan by Chen, Chieh-Lung, Wang, Sing-Ting, Liao, Wei-Chih, Chen, Chia-Hung, Tu, Chih-Yen, Chen, Hung-Jen, Hsia, Te-Chun, Cheng, Wen-Chien
Published 2022Text -
17
Meta-Analysis of in vitro-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages in vivo by Chen, Hung-Jen, Li Yim, Andrew Y. F., Griffith, Guillermo R., de Jonge, Wouter J., Mannens, Marcel M. A. M., Ferrero, Enrico, Henneman, Peter, de Winther, Menno P. J.
Published 2019Text -
18
Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses by Willemsen, Lisa, Chen, Hung-Jen, van Roomen, Cindy P. A. A., Griffith, Guillermo R., Siebeler, Ricky, Neele, Annette E., Kroon, Jeffrey, Hoeksema, Marten A., de Winther, Menno P. J.
Published 2022Text -
19
The Risk of Tuberculosis Infection in Non-dialysis Chronic Kidney Disease Patients by Li, Chia-Hsiang, Chen, Hung-Jen, Chen, Wei-Chun, Tu, Chih-Yen, Hsia, Te-Chun, Hsu, Wu-Huei, Chang, Chiz-Tzung, Huang, Chiu-Ching, Bau, Da-Tian, Chou, Che-Yi
Published 2021Text -
20
Does Chronic Obstructive Pulmonary Disease with or without Type 2 Diabetes Mellitus Influence the Risk of Lung Cancer? Result from a Population-Based Cohort Study by Shen, Te-Chun, Chung, Wei-Sheng, Lin, Cheng-Li, Wei, Chang-Ching, Chen, Chia-Hung, Chen, Hung-Jen, Tu, Chih-Yen, Hsia, Te-Chun, Shih, Chuen-Ming, Hsu, Wu-Huei, Chung, Chi-Jung
Published 2014Text